Federation des caisses Desjardins du Quebec’s Biocept, Inc. BIOC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$102	–	2597
2021 Q1	$102	Hold	1	–	–	﹤0.01%	2430
2020 Q4	$195	Hold	1	–	–	﹤0.01%	2297
2020 Q3	$194	Hold	1	–	–	﹤0.01%	2123
2020 Q2	$237	Hold	1	–	–	﹤0.01%	2064
2020 Q1	$88	Hold	1	–	–	﹤0.01%	2179
2019 Q4	$95	Hold	1	–	–	﹤0.01%	2280
2019 Q3	$298	Hold	1	–	–	﹤0.01%	2224
2019 Q2	$406	Sell	1 -1	-50%	-$317	﹤0.01%	2192
2019 Q1	$650	Hold	2	–	–	﹤0.01%	1998
2018 Q4	$486	Hold	2	–	–	﹤0.01%	2000
2018 Q3	$1.55K	Hold	2	–	–	﹤0.01%	2009
2018 Q2	$3.4K	Sell	2 -11	-85%	-$22.3K	﹤0.01%	1964
2018 Q1	$34.7K	Buy	13 +6	+86%	+$22.5K	﹤0.01%	1432
2017 Q4	$41.1K	Buy	+7	New	+$55.3K	﹤0.01%	1389

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BIOC Position: Q2 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Biocept, Inc. (BIOC) in Q2 2021, closing a stake of 1 share — an estimated $102 sold.

Federation des caisses Desjardins du Quebec first reported a position in BIOC in Q4 2017 and held it in 14 quarters. The position peaked at $41.1K in Q4 2017. 21 funds tracked by Wall St. Rank hold BIOC as of Q2 2021.

Federation des caisses Desjardins du Quebec reported no remaining Biocept, Inc. position as of Q2 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1 Biocept, Inc. share in Q2 2021, an estimated $102.
Federation des caisses Desjardins du Quebec first reported a position in Biocept, Inc. in Q4 2017 and held it in 14 quarters.
Federation des caisses Desjardins du Quebec's Biocept, Inc. position peaked at $41.1K in Q4 2017.
21 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2021, filed 30 Aug 2024.